Cell Based Assay Market Size, Share, Trends, Growth 2032

Cell Based Assay Market: Overview

The global cell based assay market size was worth around USD 18.90 billion in 2023 and is predicted to grow to around USD 40.78 billion by 2032 with a compound annual growth rate (CAGR) of roughly 8.92% between 2024 and 2032.

Request Free Sample

The report covers a forecast and an analysis of the cell based assay market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints of the cell based assay market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cell based assay market on a global and regional level.

Cell Based Assay Market: Growth Drivers

Cell assay is a diagnostic tool that is used to study cellular functions’ mechanisms. Functional cells are used as diagnostic equipment for studying new drugs. Cell-based assays are extensively used in academic institutes, research facilities, government institutes, pharmaceutical and biotechnology companies, and contract research institutes. Cell-based arrays generally measure cell toxicity, motility, proliferation of a cell and its products, and cell morphology.

The increasing incidence of chronic diseases, such as cancer, cardiovascular diseases, arthritis, and diabetes, is the primary growth factor of the cell based assay market globally. Furthermore, increasing R&D expenditure on drug discovery, the advantage of cell-based assays over other techniques, and growing adoption of throughput screening methods, mainly in toxicological studies, will have a positive impact on the cell based assay market. However, the high maintenance of instruments and their operational costs, lack of a skilled workforce, and strict regulatory requirements by the government may limit the cell based assay market.

Request Free Sample

Alternatively, the increased use of the novel cell-based assay in cancer research will further contribute to the cell cased assay market development in the future.

In order to give the users of this report a comprehensive view of the cell based assay market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the cell based assay market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the cell based assay market on a global and regional basis.

Cell Based Assay Market : Report Scope

Cell Based Assay Market: Segmentation

The study provides a decisive view of the cell based assay market by segmenting it based on application, product, end-user, and region.

On the basis of product, the cell based assay market includes microplates, reagents, services, cell lines, instruments, and assay kits. Based on application, the market is classified into ADME studies, research, predictive toxicology, and drug discovery. The drug discovery segment is anticipated to witness notable growth in the cell based assay market over the forecast time period. By end-user, the global cell based assay market includes CROs, biopharma companies, and research institutes. Biopharma companies accounted for the largest share of the cell based assay market in 2018 globally.

Cell Based Assay Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America dominated the global cell based assay market in 2018, due to the positive government initiatives for investment and funding in cancer research, flourishing pharmaceutical industry, developing economic conditions, and rising business investments. Europe held the second largest market share for the cell based assay market in 2018, due to the rising cancer prevalence, increasing cancer diagnosis procedures, and growing awareness about new advanced technologies. The Asia Pacific is an emerging region for cell based assay market, due to the increasing cancer cases, growing investments in healthcare services, and rising assay applications.

Cell Based Assay Market: Competitive Analysis

The global cell based assay market is led by players like:

• Becton
• Dickinson and Company
• Bio-Rad Laboratories
• Corning
• Danaher Corporation
• DiscoverX Corporation
• F. Hoffmann-La Roche
• Merck
• Perkin Elmer
• Promega Corporation
• Thermo Fisher Scientific

This report segments the global cell based assay market into:

Global Cell Based Assay Market: By Product

• Reagents
• Microplates
• Cell Lines
• Assay Kits
• Instruments
• Services

Global Cell Based Assay Market: By Application

• ADME Studies
• Predictive Toxicology
• Drug Discovery
• Research

Global Cell Based Assay Market: By End-User

• CROs
• Biopharma Companies
• Research Institutes

Global Cell Based Assay Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa